Patent · US Active

Detection method for low molecular weight heparin complete degradation products using hydrophilic interaction chromatography and multiple reaction monitoring tandem mass spectrometry

US10416132B2 · kind B2 · utility

0Cited by
0References
4Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 27, 2017
Grant dateSep 17, 2019
Priority date
Expiry dateJun 9, 2037

Classification

  • Technology area (CPC H)Electricity
  • CPC primaryH01J49/4215
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

A detection method for low molecular weight heparin complete degradation products using hydrophilic interaction chromatography and multiple reaction monitoring tandem mass spectrometry. Identifying the original reducing end and non-reducing end of enoxaparin sodium by means of reducing the reducing end of enoxaparin sodium, and performing hydrolysis using hydrogen peroxide. Performing quantitative analysis on all component units utilizing hydrophilic interaction chromatography and multiple reaction monitoring tandem mass spectrometry, in particular quantifying low-content special structures and characterizing low molecular weight heparin.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.